Explore

Trendline Trendline
Rosen Law Firm Investigates Disc Medicine Following FDA Rejection of Drug Application

Rosen Law Firm Investigates Disc Medicine Following FDA Rejection of Drug Application

Rosen Law Firm Investigates Disc Medicine Following FDA Rejection of Drug Application
Trendline Trendline
Rosen Law Firm Investigates Disc Medicine for Potential Securities Claims Following FDA Rejection

Rosen Law Firm Investigates Disc Medicine for Potential Securities Claims Following FDA Rejection

Rosen Law Firm Investigates Disc Medicine for Potential Securities Claims Following FDA Rejection
Trendline Trendline
ImmunityBio Faces Securities Fraud Class Action Over Misleading Claims on Cancer Drug

ImmunityBio Faces Securities Fraud Class Action Over Misleading Claims on Cancer Drug

ImmunityBio Faces Securities Fraud Class Action Over Misleading Claims on Cancer Drug
Trendline Trendline
Rosen Law Firm Urges Gartner Investors to Act Before Class Action Deadline

Rosen Law Firm Urges Gartner Investors to Act Before Class Action Deadline

Rosen Law Firm Urges Gartner Investors to Act Before Class Action Deadline
Trendline Trendline
Rosen Law Firm Investigates PennyMac Financial for Securities Misleading Claims

Rosen Law Firm Investigates PennyMac Financial for Securities Misleading Claims

Rosen Law Firm Investigates PennyMac Financial for Securities Misleading Claims
Trendline Trendline
Rosen Law Firm Files Securities Fraud Lawsuit Against SES AI Corporation Over Misleading Statements

Rosen Law Firm Files Securities Fraud Lawsuit Against SES AI Corporation Over Misleading Statements

Rosen Law Firm Files Securities Fraud Lawsuit Against SES AI Corporation Over Misleading Statements
Trendline Trendline
Rosen Law Firm Invites SES AI Corporation Investors to Lead Securities Fraud Lawsuit

Rosen Law Firm Invites SES AI Corporation Investors to Lead Securities Fraud Lawsuit

Rosen Law Firm Invites SES AI Corporation Investors to Lead Securities Fraud Lawsuit
Trendline Trendline
ImmunityBio Faces Securities Fraud Class Action Over Misleading Anktiva Claims

ImmunityBio Faces Securities Fraud Class Action Over Misleading Anktiva Claims

ImmunityBio Faces Securities Fraud Class Action Over Misleading Anktiva Claims
Trendline Trendline
Faruqi Faruqi, LLP Alerts Super Micro Investors of Class Action Deadline Amid Legal Challenges

Faruqi Faruqi, LLP Alerts Super Micro Investors of Class Action Deadline Amid Legal Challenges

Faruqi Faruqi, LLP Alerts Super Micro Investors of Class Action Deadline Amid Legal Challenges
Trendline Trendline
Rosen Law Firm Urges Gossamer Bio Investors to Act Before Class Action Deadline

Rosen Law Firm Urges Gossamer Bio Investors to Act Before Class Action Deadline

Rosen Law Firm Urges Gossamer Bio Investors to Act Before Class Action Deadline
Trendline Trendline
Rosen Law Firm Urges Super Micro Computer Investors to Act Before Class Action Deadline

Rosen Law Firm Urges Super Micro Computer Investors to Act Before Class Action Deadline

Rosen Law Firm Urges Super Micro Computer Investors to Act Before Class Action Deadline
Trendline Trendline
Rosen Law Firm Invites ImmunityBio Investors to Lead Securities Fraud Lawsuit

Rosen Law Firm Invites ImmunityBio Investors to Lead Securities Fraud Lawsuit

Rosen Law Firm Invites ImmunityBio Investors to Lead Securities Fraud Lawsuit